PTC Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ. 

CEO
Matthew B. Klein
CEOMatthew B. Klein
Employees
991
Employees991
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
1998
Founded1998
Employees
991
Employees991

PTCT Key Statistics

Market cap
6.09B
Market cap6.09B
Price-Earnings ratio
-31.33
Price-Earnings ratio-31.33
Dividend yield
Dividend yield
Average volume
1.18M
Average volume1.18M
High today
$75.08
High today$75.08
Low today
$72.72
Low today$72.72
Open price
$73.63
Open price$73.63
Volume
1.18M
Volume1.18M
52 Week high
$87.50
52 Week high$87.50
52 Week low
$43.18
52 Week low$43.18

Stock Snapshot

As of today, PTC Therapeutics(PTCT) shares are valued at $73.35. The company's market cap stands at 6.09B, with a P/E ratio of -31.33.

On 2026-06-10, PTC Therapeutics(PTCT) stock moved within a range of $72.72 to $75.08. With shares now at $73.35, the stock is trading +0.9% above its intraday low and -2.3% below the session's peak.

Trading activity shows a volume of 1.18M, compared to an average daily volume of 1.18M.

Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $87.50 and a low of $43.18.

Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $87.50 and a low of $43.18.

PTCT News

TipRanks 1d
PTC Therapeutics Director Resigns, Moves to Advisory Role

PTC Therapeutics ( (PTCT) ) has provided an announcement. On June 8, 2026, PTC Therapeutics, Inc. announced that board member Alethia Young resigned from the c...

Simply Wall St 5d
A Look At PTC Therapeutics Valuation As Models Flag A Potential Discount

Advertisement PTC Therapeutics stock snapshot PTC Therapeutics (PTCT) has drawn investor attention after recent share price moves, with the stock last closing...

A Look At PTC Therapeutics Valuation As Models Flag A Potential Discount

Analyst ratings

79%

of 14 ratings
Buy
78.6%
Hold
14.3%
Sell
7.1%

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.